| Literature DB >> 32340213 |
Xiang Zhang1,2, Jihua Xu1,3, Zhaobo Xu4, Xiaohong Sun1,3, Jun Zhu1,2, Yugang Zhang1,2.
Abstract
In this research, we compared the phenotypical characters, total anthocyanins content, total phenols content, and antioxidant activity of red-fleshed apple cultivars 'XJ4', 'QN-5', 'DH' and 'HX1' at three fruit developmental stages. A further flavonoids metabolites study was conducted in 'XJ4' and 'DH'. We found broader variation of total anthocyanins content in the peel of the four cultivars, which might result in larger differences of free radicals scavenging rate. The most significant difference in fruit phenotype, anthocyanins content, and DPPH scavenging rate was observed between 'XJ4' and 'DH' at mature stage. Therefore, the flavonoids metabolites of 'XJ4' and 'DH' at mature stage were compared to unveil the details of anthocyanins compounds. The unique compounds pelargonidin 3-O-β-d-glucoside and cyanidin-3-O-malonylhexoside were detected only in peel and flesh of 'XJ4' but not in 'DH', which might contribute to the purple peel and dark-red flesh color of 'XJ4'. Significantly decreased upstream metabolites in the early biosynthetic genes regulated domain were found only in 'XJ4' peel but not in the flesh. This might explain why the anthocyanins content in 'XJ4' peel was decreased largely at the mature stage. Taken together, our findings will give some insight into the metabolites study in flavonoid biosynthetic pathway of red-fleshed apple.Entities:
Keywords: anthocyanins; antioxidant activity; flavonoids; metabolites; polyphenols; red-fleshed apple
Year: 2020 PMID: 32340213 PMCID: PMC7221745 DOI: 10.3390/molecules25081968
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Fruit phenotypic characters of four different red-fleshed apple cultivars at young, developmental and mature stages. The longitudinal section and intact fruit at young stage (A,B), developmental stage (C,D), and mature stage (E,F) were present.
Total anthocyanins and total phenols content in peel and flesh of four phenotypically different red-fleshed apples at young, developmental and mature stages.
| Variety of Red-Fleshed Apple | TAC | TPC | ||
|---|---|---|---|---|
| Peel | Flesh | Peel | Flesh | |
|
| ||||
| XJ4 | 1702.6 ± 75.4a | 516.3 ± 35.6a | 8114.4 ± 152.4a | 3724.4 ± 359.9b |
| QN-5 | 461.3 ± 20.6b | 355.1 ± 118.4b | 3233.6 ± 675.8cd | 2522.6 ± 935.3cd |
| DH | 170.6 ± 47.5d | 99.9 ± 46.1c | 5277.3 ± 1229.1b | 3269.2 ± 288.9bc |
| HX1 | 109.1 ± 25.9de | 66.5 ± 1.9cd | 9082.3 ± 717.1a | 5346.1 ± 450.8a |
|
| ||||
| XJ4 | 1506 ± 101.4a | 631 ± 38.7a | 5460.3 ± 532.3b | 2397.1 ± 699.5cd |
| QN-5 | 253.1 ± 46.9c | 361 ± 45.5b | 2724.6 ± 247.7cde | 1198.8 ± 181.2e |
| DH | 35 ± 15f | 54.2 ± 34.5cd | 3171.2 ± 528.1cd | 1127.1 ± 163.1e |
| HX1 | 111 ± 71.1de | 71.5 ± 11.7c | 2636.5 ± 154.5cde | 1974.9 ± 373.7d |
|
| ||||
| XJ4 | 441 ± 76.3b | 401 ± 13.5b | 3333.9 ± 432.2c | 2283.6 ± 520.2cd |
| QN-5 | 93.4 ± 3.3de | 76.6 ± 16.1c | 1239.6 ± 481.4f | 327.6 ± 54.4f |
| DH | 12.1 ± 3.4f | 24.3 ± 6.7d | 2069.3 ± 276de | 1010.2 ± 280.6e |
| HX1 | 80.1 ± 13.4e | 57.3 ± 1.1cd | 2691.9 ± 239.7cde | 1598.8 ± 287.3de |
TAC means Total Anthocyanins Content (cyanidin 3-O-glucoside equivalents, mg·kg−1); TPC means Total Phenols Content (gallic acid equivalents, mg·kg−1). Within samples, the significant difference (p < 0.05) is represented by different letters (a, b, c, d, e and f).
In vitro antioxidant activity of anthocyanins extract from peel and flesh of four phenotypically different red-fleshed apples at young, developmental and mature stages.
| Variety of Red-Fleshed Apple | Scavenging Rate of DPPH/% | Scavenging Rate of | Scavenging Rate of | Dilution Ratio | ||||
|---|---|---|---|---|---|---|---|---|
| Peel | Flesh | Peel | Flesh | Peel | Flesh | Peel | Flesh | |
|
| ||||||||
| XJ4 | 57.7 ± 2.8de | 80.9 ± 7.8ab | 14.3 ± 1.5e | 31.4 ± 8.0c | 22.1 ± 1.0d | 12 ± 4.6f | 34.0 | 10.3 |
| QN-5 | 88.1 ± 0.8a | 85.7 ± 1.0ab | 46.1 ± 2.9c | 49.5 ± 8.1b | 11.1 ± 1.3e | 18.4 ± 2.9ef | 9.2 | 7.1 |
| DH | 84.7 ± 6.1ab | 81.2 ± 3.8ab | 49.2 ± 5.6bc | 38.5 ± 1.7c | 27.2 ± 0.7cd | 27.6 ± 0.7cde | 3.4 | 2.0 |
| HX1 | 70.9 ± 1.7bc | 81.4 ± 3.6ab | 81.5 ± 7.3a | 51.6 ± 11.2b | 21.7 ± 0.8d | 15.3 ± 1.6ef | 2.1 | 1.3 |
|
| ||||||||
| XJ4 | 90.7 ± 9.0a | 84.5 ± 1.6ab | 33.7 ± 3.1d | 37.3 ± 3.5c | 47.7 ± 12.6ab | 31.7 ± 2.4abc | 30.1 | 12.6 |
| QN-5 | 94.7 ± 0.2a | 94.6 ± 0.2ab | 43 ± 4.0cd | 54 ± 3.9b | 52.7 ± 4.8a | 25.9 ± 10.1cde | 5.0 | 7.2 |
| DH | 48.5 ± 10.2e | 80 ± 3.2b | 40.1 ± 6.0cd | 13.8 ± 3.1e | 29.4 ± 7.4cd | 21.1 ± 4.1def | −1.4 | 1.0 |
| HX1 | 65.8 ± 1.3cd | 83.5 ± 0.7ab | 41.8 ± 3.6cd | 34.2 ± 6.1c | 31.1 ± 3.2bcd | 17.1 ± 3.1ef | 2.2 | 1.4 |
|
| ||||||||
| XJ4 | 90.6 ± 2.1a | 97.1 ± 1.2a | 59.4 ± 8.6b | 75.1 ± 0.71a | 39.7 ± 2.7abc | 39.9 ± 2.5ab | 8.8 | 8.0 |
| QN-5 | 93.3 ± 2.5a | 94.7 ± 0.4ab | 2.4 ± 1.0g | 1.5 ± 0.4g | 38 ± 4.8abc | 43.3 ± 4.8a | 1.8 | 1.5 |
| DH | 21.4 ± 4.5f | 46.5 ± 3.0c | 48.9 ± 8.4bc | 20.1 ± 5.7d | 39 ± 3.2abc | 47.1 ± 4.7a | −4.6 | −2 |
| HX1 | 82.7 ± 1.6ab | 88.3 ± 0.9ab | 15.2 ± 3.0e | 4.3 ± 0.1f | 32.2 ± 2.5bcd | 36.8 ± 3.1abc | 1.6 | 1.1 |
| VC | 3.6 ± 1.6g | 3.6 ± 1.6d | 9.1 ± 0.8f | 9.1 ± 0.8e | 19.1 ± 9.0d | 19.1 ± 9.0ef | ||
The significant difference (p < 0.05) is represented by different letters (a, b, c, d, e and f).
Figure 2Heat map of significantly differential flavonoids metabolites in DHPM vs. XJ4PM. Red and green color indicates the content of significant differential metabolites, respectively. Columns and rows represent samples and individual metabolites, respectively. The depth of color indicates the value of correlation coefficient.
Figure 3Heat map of significantly differential flavonoids metabolites in DHFM vs. XJ4FM. Red and green color indicates the content of significant differential metabolites, respectively. Columns and rows represent samples and individual metabolites, respectively. The depth of color indicates the value of correlation coefficient.
Figure 4Volcano plot and number of upregulated and downregulated significantly differential flavonoids metabolites in four comparison groups. (A,B) Volcano plot of DHPM vs. XJ4PM and DHFM vs. XJ4FM. Green, red and black dots represents the number of significantly downregulated, upregulated and unchanged metabolites. (C,D) Number of significantly upregulated and downregulated metabolites (SDM) in two comparison groups DHPM vs. XJ4PM and DHFM vs. XJ4FM. SDM represents significantly differential metabolites.
Figure 5The proportion of significantly differential flavonoids metabolites in peel and flesh comparison groups. (A) DHPM vs. XJ4PM, (B) DHFM vs. XJ4FM.
The extremely significantly different metabolites in DHPM vs. XJ4PM and DHFM vs. XJ4FM.
| Combination Name | Metabolite Name | Content | Fold Change (XJ4PM/DHPM; XJ4FM/DHFM) | VIP | Grouping of Specific Metabolites | |
|---|---|---|---|---|---|---|
| DH | XJ4 | |||||
|
| ||||||
| DHPM vs. XJ4PM | Pelargonidin 3- | 9.00E + 00 | 3.14E + 07 | 3.49E + 06 | 2.36 | XJ4PM |
| Cyanidin 3- | 9.00E + 00 | 1.32E + 06 | 1.47E + 05 | 2.1 | XJ4PM | |
| Malvidin 3-acetyl-5-diglucoside | 9.00E + 00 | 2.56E + 05 | 2.84E + 04 | 1.93 | XJ4PM | |
| Cyanidin 3- | 9.00E + 00 | 2.40E + 05 | 2.67E + 04 | 1.94 | XJ4PM | |
| Pelargonidin 3- | 9.00E + 00 | 1.63E + 04 | 1.82E + 03 | 1.65 | XJ4PM | |
| DHFM vs. XJ4FM | Pelargonidin 3- | 9.00E + 00 | 6.78E + 07 | 7.54E + 06 | 2.16 | XJ4FM |
| Cyanidin 3- | 9.00E + 00 | 1.56E + 06 | 1.74E + 05 | 1.89 | XJ4FM | |
| Malvidin 3-acetyl-5-diglucoside | 9.00E + 00 | 1.06E + 06 | 1.17E + 05 | 1.86 | XJ4FM | |
| Peonidin | 9.00E + 00 | 7.50E + 05 | 8.33E + 04 | 1.83 | XJ4FM | |
| Peonidin 3- | 9.00E + 00 | 7.12E + 05 | 7.91E + 04 | 1.83 | XJ4FM | |
| Pelargonidin 3- | 9.00E + 00 | 2.49E + 04 | 2.76E + 03 | 1.53 | XJ4FM | |
| Rosinidin | 7.00E + 04 | 9.00E + 00 | 1.29E-04 | 1.62 | DHFM | |
|
| ||||||
| DHPM vs. XJ4PM | Selgin | 9.00E + 00 | 3.09E + 06 | 3.43E + 05 | 2.17 | XJ4PM |
| Tricin | 9.00E + 00 | 3.02E + 06 | 3.36E + 05 | 2.16 | XJ4PM | |
| 6-C-hexosyl-hesperetin | 9.00E + 00 | 2.41E + 06 | 2.68E + 05 | 2.14 | XJ4PM | |
| Luteolin 3’,7-di- | 9.00E + 00 | 1.26E + 06 | 1.39E + 05 | 2.09 | XJ4PM | |
| 9.00E + 00 | 1.09E + 06 | 1.22E + 05 | 1.38 | XJ4PM | ||
| 9.00E + 00 | 1.09E + 06 | 1.21E + 05 | 1.37 | XJ4PM | ||
| C-hexosyl-apigenin | 9.00E + 00 | 8.63E + 05 | 9.59E + 04 | 2.05 | XJ4PM | |
| Eriodictiol 6-C-hexoside 8-C-hexoside- | 9.00E + 00 | 5.88E + 05 | 6.54E + 04 | 2.02 | XJ4PM | |
| Hesperetin C-hexosyl- | 9.00E + 00 | 5.85E + 05 | 6.50E + 04 | 2.02 | XJ4PM | |
| C-hexosyl-isorhamnetin | 9.00E + 00 | 1.67E + 05 | 1.86E + 04 | 1.9 | XJ4PM | |
| Tricin 4′- | 9.00E + 00 | 1.55E + 05 | 1.73E + 04 | 1.89 | XJ4PM | |
| Morin | 9.00E + 00 | 7.46E + 05 | 8.29E + 04 | 2.04 | XJ4PM | |
| Persicoside | 9.00E + 00 | 5.93E + 05 | 6.59E + 04 | 2.02 | XJ4PM | |
| Chrysoeriol 8-C-hexoside | 9.00E + 00 | 4.92E + 04 | 5.47E + 03 | 1.25 | XJ4PM | |
| Apigenin | 9.00E + 00 | 4.38E + 04 | 4.87E + 03 | 1.22 | XJ4PM | |
| Acacetin | 9.00E + 00 | 3.31E + 04 | 3.68E + 03 | 1.66 | XJ4PM | |
| Tricin 5- | 9.00E + 00 | 1.14E + 04 | 1.26E + 03 | 1.15 | XJ4PM | |
| Baicalein-7- | 5.51E + 04 | 9.00E + 00 | 1.63E-04 | 1.79 | DHPM | |
| Diosmin | 2.21E + 06 | 9.00E + 00 | 4.08E-06 | 2.11 | DHPM | |
| Chrysoeriol 7- | 9.30E + 05 | 9.00E + 00 | 9.67E-06 | 2.03 | DHPM | |
| DHFM vs. XJ4FM | 6-C-hexosyl-hesperetin | 9.00E + 00 | 7.26E + 06 | 8.06E + 05 | 2 | XJ4FM |
| Luteolin 3’,7-di- | 9.00E + 00 | 3.64E + 06 | 4.04E + 05 | 1.95 | XJ4FM | |
| Selgin | 9.00E + 00 | 1.98E + 06 | 2.20E + 05 | 1.91 | XJ4FM | |
| 8-C-hexosyl-hesperetin | 9.00E + 00 | 6.70E + 05 | 7.45E + 04 | 1.82 | XJ4FM | |
| Eriodictiol 6-C-hexoside 8-C-hexoside- | 9.00E + 00 | 6.06E + 05 | 6.74E + 04 | 1.81 | XJ4FM | |
| Hesperetin C-hexosyl- | 9.00E + 00 | 4.05E + 05 | 4.50E + 04 | 1.78 | XJ4FM | |
| Limocitrin | 9.00E + 00 | 3.43E + 05 | 3.81E + 04 | 1.77 | XJ4FM | |
| Chrysoeriol 8-C-hexoside | 9.00E + 00 | 2.49E + 05 | 2.76E + 04 | 1.74 | XJ4FM | |
| Chrysoeriol 6-C-hexoside 8-C-hexoside- | 9.00E + 00 | 2.28E + 05 | 2.53E + 04 | 1.73 | XJ4FM | |
| Butin | 9.00E + 00 | 1.82E + 05 | 2.02E + 04 | 1.71 | XJ4FM | |
| Eriocitrin | 9.00E + 00 | 7.77E + 04 | 8.63E + 03 | 1.64 | XJ4FM | |
| Tricin | 9.00E + 00 | 5.43E + 04 | 6.03E + 03 | 1.6 | XJ4FM | |
| 9.00E + 00 | 4.73E + 04 | 5.26E + 03 | 1.59 | XJ4FM | ||
| Tricin 5- | 9.00E + 00 | 4.45E + 04 | 4.94E + 03 | 1.59 | XJ4FM | |
| 9.00E + 00 | 3.99E + 04 | 4.43E + 03 | 1.58 | XJ4FM | ||
| Apigenin | 9.00E + 00 | 1.39E + 04 | 1.55E + 03 | 1.03 | XJ4FM | |
| Chrysoeriol | 9.00E + 00 | 7.42E + 03 | 8.25E + 02 | 1.41 | XJ4FM | |
| Chrysoeriol 7- | 1.68E + 04 | 9.00E + 00 | 5.37E-04 | 1.04 | DHFM | |
| C-hexosyl-luteolin | 2.41E + 04 | 9.00E + 00 | 3.74E-04 | 1.52 | DHFM | |
| Luteolin C-hexoside | 2.42E + 04 | 9.00E + 00 | 3.72E-04 | 1.53 | DHFM | |
| 6-C-hexosyl luteolin | 3.15E + 04 | 9.00E + 00 | 2.86E-04 | 1.09 | DHFM | |
| Diosmin | 3.20E + 04 | 9.00E + 00 | 2.81E-04 | 1.08 | DHFM | |
| Luteolin | 4.34E + 04 | 9.00E + 00 | 2.07E-04 | 1.58 | DHFM | |
| 3- | 4.79E + 04 | 9.00E + 00 | 1.88E-04 | 1.53 | DHFM | |
|
| ||||||
| DHPM vs. XJ4PM | Quercetin | 9.00E + 00 | 5.59E + 05 | 6.21E + 04 | 2.02 | XJ4PM |
| Laricitrin | 9.00E + 00 | 6.04E + 04 | 6.71E + 03 | 1.8 | XJ4PM | |
| Isorhamnetin | 9.00E + 00 | 2.26E + 04 | 2.51E + 03 | 1.7 | XJ4PM | |
| Rhamnetin (7- | 9.00E + 00 | 3.26E + 03 | 3.62E + 02 | 1.47 | XJ4PM | |
| Kaempferol 3- | 1.16E + 06 | 9.00E + 00 | 7.77E-06 | 2.08 | DHPM | |
| DHFM vs. XJ4FM | Syringetin 3- | 9.00E + 00 | 4.68E + 05 | 5.20E + 04 | 1.79 | XJ4FM |
| Rhamnetin | 9.00E + 00 | 5.00E + 03 | 5.56E + 02 | 1.36 | XJ4FM | |
| Isorhamnetin 3- | 1.08E + 04 | 9.00E + 00 | 8.33E-04 | 1.01 | DHFM | |
| Kaempferol 3- | 3.84E + 04 | 9.00E + 00 | 2.34E-04 | 1.1 | DHFM | |
| Syringetin | 6.33E + 04 | 9.00E + 00 | 1.42E-04 | 1.6 | DHFM | |
|
| ||||||
| DHPM vs. XJ4PM | Hesperetin | 9.00E + 00 | 1.22E + 05 | 1.35E + 04 | 1.87 | XJ4PM |
| DHFM vs. XJ4FM | Naringenin | 9.00E + 00 | 1.92E + 05 | 2.13E + 04 | 1.72 | XJ4FM |
| Hesperetin | 9.00E + 00 | 1.55E + 05 | 1.72E + 04 | 1.7 | XJ4FM | |
| Naringenin 7- | 9.00E + 00 | 9.60E + 04 | 1.07E + 04 | 1.66 | XJ4FM | |
| Hesperetin | 9.00E + 00 | 4.25E + 04 | 4.72E + 03 | 1.58 | XJ4FM | |
|
| ||||||
| DHPM vs. XJ4PM | Genistein 7- | 9.00E + 00 | 1.87E + 05 | 2.08E + 04 | 1.92 | XJ4PM |
| DHFM vs. XJ4FM | Rotenone | 9.00E + 00 | 4.27E + 04 | 4.74E + 03 | 1.58 | XJ4FM |
| Genistein 7- | 9.00E + 00 | 2.79E + 04 | 3.10E + 03 | 1.08 | XJ4FM | |
| Glycitein | 9.00E + 00 | 9.10E + 03 | 1.01E + 03 | 1.43 | XJ4FM | |
| Calycosin | 9.00E + 00 | 6.75E + 03 | 7.50E + 02 | 1.4 | XJ4FM | |
|
| ||||||
| DHFM vs. XJ4FM | Gallocatechin-gallocatechin | 9.00E + 00 | 2.90E + 07 | 3.23E + 06 | 2.11 | XJ4FM |
Figure 6Enrichment analysis of KEGG pathway. (A,B) present the enrichment analysis of KEGG pathway in DHPM vs. XJ4PM, DHFM vs. XJ4FM respectively. The color and size of the dots represented p value and the amount of enriched differential metabolites, respectively. Rich factor means the ratio of the number of differential metabolites to the total number of metabolites enriched in a specific category.
Figure 7Profiles of differential metabolites in flavonoid biosynthesis pathways in DHPM vs. XJ4PM. The box in the pathway represents differential metabolites. Red and green represent upregulated and downregulated metabolites in content. Solid lines and dotted lines represent significant differences and insignificant differences, respectively.
Figure 8Profiles of differential metabolites in flavonoid biosynthetic pathways in DHFM vs. XJ4FM. The box in the pathway represents differential metabolites. Red and green represent upregulated and downregulated metabolites in content. Solid lines and dotted lines represent significant differences and insignificant differences, respectively.